-
Tips for becoming a good boxer - November 6, 2020
-
7 expert tips for making your hens night a memorable one - November 6, 2020
-
5 reasons to host your Christmas party on a cruise boat - November 6, 2020
-
What to do when you’re charged with a crime - November 6, 2020
-
Should you get one or multiple dogs? Here’s all you need to know - November 3, 2020
-
A Guide: How to Build Your Very Own Magic Mirror - February 14, 2019
-
Our Top Inspirational Baseball Stars - November 24, 2018
-
Five Tech Tools That Will Help You Turn Your Blog into a Business - November 24, 2018
-
How to Indulge on Vacation without Expanding Your Waist - November 9, 2018
-
5 Strategies for Businesses to Appeal to Today’s Increasingly Mobile-Crazed Customers - November 9, 2018
Abbott eases its M&A risk with $4.3 bln asset sale
Johnson & Johnson agreed to buy Abbott Laboratories’ eye-surgery equipment unit for $4.33 billion, moving the health-care giant toward its goal of boosting its three core businesses.
Advertisement
Rather than going down the hard path of trying to build up its presence in the already competitive lens market, Abbott has found a good home for a division that didn’t really have that much in common with the rest of its device business anyway.
The purchase price works out to about 3.6 times the $1.2 billion in sales that Wells Fargo analyst Larry Biegelsen estimates Abbott Medical Optics will bring in for 2016.
Abbott, a pharmaceutical company based out of Lake Bluff, Illinois, chose to exit the eye care segment called Abbott Medical Optics that makes lasers and other equipment used for cataract surgeries and laser vision correction procedures, which was not in synergy with its other businesses. But it doesn’t mean that Abbott is going to actually do both deals, as much as Alere shareholders seemed to hope was the case when they sent the company’s stock up about 2.7 percent on Friday.
Last Friday’s deal, which is expected to close in the first quarter of 2017, is expected to modestly add to J&J’s earnings immediately.
Abbott Medical Optics, which the company acquired for almost US$1.4bil in 2009, reported sales of US$1.1bil for 2015, J&J said last Friday. “Importantly, with this acquisition we will enter cataract surgery – one of the most commonly performed surgeries and the number one cause of preventable blindness”. These numbers are steadily rising because of population growth and increasing life expectancy. It also makes eye drops and cleaners for contact lenses.
Range Resources Corp. (NYSE:RRC), lost -5.05% and closed at $37.38 in the last trading session. RANGE RESOURCES CORPORATION “Range” (RRC) and MEMORIAL RESOURCE DEVELOPMENT CORP.
Advertisement
There has been a wave of mergers among medical-device companies in recent years. The combination of the two highest quality natural gas plays in the United States provides Range with a strong foundation to create sustainable shareholder value, while our extensive, regionally-diverse drilling inventory allows us to continue improving our already class-leading cost structure and further drive operational and marketing efficiencies.